Oregon Pertussis Guidelines: Before & After Juventila Liko, MD, MPH Paul Lewis, MD Oregon State Public Health March 18, 2008.

Slides:



Advertisements
Similar presentations
Pertussis Prevention for Pregnant Women: P 3 W Protecting Infants.
Advertisements

Perinatal HIV Testing in Utah Lois Blobaum, BSN, Theresa Garrett, MSN and Nan Streeter, RN, MS Utah Department of Health.
Team Membership Stephanie Detterline, MD Mary E. Altier, MSN, RN Clinical Departments: Emergency Medical Services, General Medicine, Cardiac Services Hospital.
Decreasing Incidence of Pertussis in Massachusetts Following the Introduction of Tdap Noelle Cocoros, Nancy Harrington, Rosa Hernandez, Jennifer Myers,
Validity of Polymerase Chain Reaction Using Liquid Transport Media During a Pertussis Outbreak Cynthia Schulte, RN, BSN VPD Surveillance Officer Bureau.
Plans to Assess the Effectiveness of Seasonal and Pandemic Influenza Vaccines during David Shay MD, MPH (Prevention Assessment and Modeling Team.
Current Pandemic H1N1 Updates in the Philippines Department of Health, Philippines Juan M. Lopez, MD, PGradDipPH, MPH Aldrin Q. Reyes, RN.
School-Based Varicella Surveillance Palm Beach County, Florida 42 nd National Immunization Conference March 17, 2008 Savita Kumar, MD, MSPH Medical Epidemiologist.
Measles victim leaves house despite warning
Linda K. Ohri, PharmD, MPH, Natalie Van Heek, PharmD Candidate, Ted Kasha, BS Jkjkj.
Using Surveillance Indicators for Vaccine-Preventable Diseases: National Notifiable Diseases Surveillance System Sandra W. Roush, MT, MPH National.
Characterization of a Large Mumps Outbreak Among Adolescents in Jerusalem, Israel in Communities Associated with Jewish Communities in New York.
Children’s Outcomes Research Program The Children’s Hospital Aurora, CO Children’s Outcomes Research Program The Children’s Hospital Aurora, CO Colorado.
Amanda E. Faulkner, MPH Surveillance Coordinator 2011 National Immunization Conference March 30, 2011 Zooming in on Pertussis Epidemiology in the United.
Sharing Immunization Data between IHS/Tribal Facilities and the Arizona State Immunization Information System Scott Hamstra, MD (IHS) Kimiko Gosney, MS.
A New Way of Thinking: Pertussis Outbreak Management and Control Help Us Shape the Future of CDC’s Pertussis Outbreak Guidelines Jennifer L. Liang, DVM,
Mumps Outbreaks Associated with Correctional Facilities Texas
National Tuberculosis Genotyping Service
1University of Kentucky, Lexington, Kentucky
National Hepatitis Coordinators’ Conference 2003 Thanks for having me!
Pengjun Lu, PhD, MPH;1 Kathy Byrd, MD, MPH;2
A decision analysis of pertussis control measures
Evaluation Report: April 1, 2015 – March 31, 2016
Sandor Feldman MD Immunization Consultant And Joyce Booth RN, MSN
C. Mary Healy, Betsy H. Mayes, Marcia A. Rench
Cynthia F. Hinton, PhD, MS, MPH
Patterns of psychiatric hospital admission for schizophrenia and related psychosis in England: A retrospective cross-sectional survey Thompson A. D.¹,
Partnerships for Pandemic & Bioterrorism Incidents
VFC Site Visit Questionnaire and AFIX as Tools for Quality Assessment
Vaccination Rates in Idaho: Updates Fall 2017
2007 American Public Health Association
Christina Dorell, MD, MPH
ACIP Feb , 2007 Guillain-Barré Syndrome (GBS) Among Recipients of Meningococcal Conjugate Vaccine (MCV4,Menactra®) Update Oct Jan Robert.
Prevention of Influenza in Infants by Immunization of Their Contacts in the Household Emmanuel Walter MD, MPH 30 March 2009.
What’s going on out there
Maria del Rosario, MD, MPH Arianna DeBarr, RN, BSN
Ten Years of Human Papillomavirus Vaccination in the United States
Implementation Issues for HPV Vaccine
Primary Care Alternatives PRC Results
Increasing Capacity to Provide Immunization Services
RISK R isk of Perinatal and Early Childhood Infection
Research Update 2017/18 Dr Bernadette Matthews
Prevention of mother to child transmission and early infant diagnosis in Malawi: Accomplishments of a mature Option B+ program in a resource-limited setting.
Evolution of Pertussis Diagnostic Testing in the U.S. :
Women’s Health Care and Education Coalition
Peng-jun Lu, MD, PhD1; Mei-Chun Hung, MPH, PhD1,2 ; Alissa C
Title goes here Sub title goes here
Dialing up for Teen Shots: Immunization Status of San Diego County Adolescents Wendy Wang, MPH County of San Diego ● Health and Human Services Agency.
Pediatric Inactivated Influenza Vaccine Safety VAERS Reports for Trivalent Inactivated Influenza Vaccine (TIV) in Infants/Toddlers Ann McMahon, MD, MS.
Physician Adoption of Adolescent Tdap Recommendations
Trudy V. Murphy, MD March 8, 2006 National Immunization Program
Vaccination coverage of U. S
CDPH, Immunization Branch
Adolescent and Adult ACIP Update
Pertussis/Flu Update 9/28/2010
M Javanbakht, S Guerry, LV Smith, P Kerndt
Contact: Anuradha Bhatt, MPH
Varicella Vaccine Efficacy Estimates
Rachel Wiseman1, MPH; David G
Zhen Zhao, PhD and Holly A. Hill, MD, PhD
National Immunization Conference
National Immunization Conference
Akiko C. Kimura, MD Jeffrey Higa, MPH Christine Nguyen, MPH
HPV Vaccination in Communities with High Rates of Cervical Cancer:
Mumps Vaccine Effectiveness During an Outbreak in New York City
Varicella Disease Incidence During the Introduction of a Routine Two Dose Varicella Vaccination Program, Antelope Valley, California, Amanuel.
Adherence to New Pediatric Recommendations for Influenza Vaccination Among Pediatric and Family Medicine Physicians Allison Kempe, MD, MPH.
ONE ARM OR TWO? CONCURRENT ADMINISTRATION OF MENINGOCOCCAL C CONJUGATE AND HEPATITIS B VACCINES IN PRE-TEENS Karen Pielak RN MSN Nurse Epidemiologist.
Philip Huang, MD, MPH Director/ Health Authority
Presentation transcript:

Oregon Pertussis Guidelines: Before & After Juventila Liko, MD, MPH Paul Lewis, MD Oregon State Public Health March 18, 2008

Objectives Review Oregon’s recent pertussis trends Summarize revisions to Oregon's Pertussis Investigation Guidelines Present findings of workload impact study

New guideline OR U.S.

New guideline

Presumed and Confirmed Pertussis in Oregon,

Pertussis Outbreaks (> 2 cases) in OR Most outbreaks detected in schools

Oregon’s Take on Tdap for Schools Recommendations –Routinely at yrs if 5 yrs from previous dose –1 dose any time during teens if not received at yrs –State-supplied for VFC eligibles and others served at public clinics Requirements –Pertussis vaccine required for 7 th grade starting Fall Requirement will be phased in one grade level per year through 12 th grade.

Pertussis in Benton County, 2004 Spring Break End of School Start of School Thanksgiving Christmas IR = 274/100,000 N = 224 Courtesy of Tasha Poissant, MPH - Benton County Health Dept.

IR: 209/100,000 Median age 15 yrs 81% were associated with schools. Middle school Tdap Before 15% After 61% High school Tdap Before 9% After 51% Vaccination Campaign

Oregon’s Revised Pertussis Guideline

Key Features of Pertussis Guideline Case definitions - Confirmed case= Culture or PCR + clinical signs - Presumptive case=Epi link to a confirmed case + clinical signs. Changes in prophylaxis - Infants - Pregnant women - Households with above Changes in antibiotic dosage and duration (erythromycin ) - Erythromycin max 1gr/day for 7 days

Evaluation of New Pertussis Guideline

Methods: A retrospective review was conducted of all reported patients who were diagnosed with pertussis before and after guideline change 07/ /2004 and 07/ /2005 A survey also was conducted to assess the impact of the new guideline on the LHDs workload

Pertussis in Oregon, Old Guideline 7/04-12/04 New Guideline 7/05-12/05 Cases Lab-confirmed 180 (47%)105 (70%) Mean age 17.3 yrs13.7 yrs Hospitalizations 14 (93% infants, 86% < 4mos) 11 (82% infants, 72% < 4mos)

Pertussis in Oregon, Old Guideline 7/04-12/04 New Guideline 7/05-12/05 Statistics Contacts1900 (avg=5/case; median=3) 569 (avg=4/case; median=3) Prophylaxis1596 (84%)221 (39%)RR=1.8 95%CI ( ) P<0.001 High Risk (HR) contacts 39 (2%)41 (7%)RR=2.1 95%( ) P<0.001 Time to prophylax HR Mean=2 days Median=1 day Mean=1.7 days Median=1 day Not sig. Secondary cases25 (1.3%)4 (0.7%)Not sig.

Pertussis Guideline Survey of LHDs 10 ITEM SURVEY SENT TO LHDs 61% RESPONSE RATE 88% outbreak experience 94 % self-explanatory guideline 96% experienced with pertussis 70 % less time spent for case investigation On-going Concerns 41% time spent on education 70% lack of insurance 53% safety concerns non high- risk contacts Recommendation Update the vaccine section

Limitations “ Oh, that’s too bad…”  Retrospective Study  Testing bias  Guideline changed  Case report changed

SUMMARY The number of prescriptions for prophylaxis per case has dropped significantly There is a significant increase in the proportion of infants and pregnant women identified LHDs report spending less time on the case investigations

Acknowledgements OPHD Paul Cieslak, MD Martha Skiles, MPH Yangdol Sherpa Michelle Barber, MS Sara Beaudrault, MPH Stacy de Assis Matthews, MPH Kathy Scott, DrPH CDC Tejpratap Tiwari, MD LHDs Eileen Marma, RN Mary Shaughnessy, RN Tasha Poissant, MPH Karen Landers, MD Amy Sullivan, PhD Trevor Hostetler, RN Cheryl Keniston, RN Melanie Thomas, RN BC CDC Karen Pielak, RN, MSN

THANK YOU